SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12.32 |
| Enterprise Value ($M) | -6.88 |
| Book Value ($M) | 18.56 |
| Book Value / Share | 1.73 |
| Price / Book | 0.66 |
| NCAV ($M) | 18.56 |
| NCAV / Share | 1.73 |
| Price / NCAV | 0.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.58 |
| Return on Assets (ROA) | -0.76 |
| Return on Equity (ROE) | -0.91 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.36 |
| Current Ratio | 6.36 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 22.02 |
| Assets | 22.02 |
| Liabilities | 3.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 6.59 |
| Operating Income | -11.12 |
| Net Income | -10.73 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -10.91 |
| Cash from Investing | 0.00 |
| Cash from Financing | 14.99 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Alyeska Investment Group, L.P. | 9.99 | ||
| 13G | Blue Owl Capital Holdings LP | 5.18 | ||
| 13D/A | New Enterprise Associates 16, L.P. | 15.20 | 51.73 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 14,614 | 56,225 | 25.99 | |
| 12,926 | 34,432 | 37.54 | |
| 5,830 | 20,184 | 28.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MIRA – MIRA Pharmaceuticals, Inc. | MLTX – MoonLake Immunotherapeutics |
| MNPR – Monopar Therapeutics Inc. | MTEX – Mannatech, Incorporated |
| MTVA – MetaVia Inc. |
Financial data and stock pages provided by
Fintel.io